Brazil’s health regulator Anvisa on Monday set a deadline of 10 days to analyze the emergency authorization for COVID-19 vaccines. The period is valid for immunizers who have done clinical tests in Brazil. Currently, there are four vaccines in this situation, and so far none has made the request to Anvisa.
Anvisa’s teams will continue to work during the Christmas and New Year holidays. Brazil’s health regulator also said on Monday that China’s health authorities are not transparent in their authorization of COVID-19 vaccines for emergency use, reported Reuters.
Meanwhile, Sao Paulo Governor Joao Doria, a Bolsonaro enemy, said the state expected to start vaccinating its residents in January, though Brazil’s most populous state will not be able to use CoronaVac until it is approved by Anvisa.
“Brazil is the international leader in the evaluation process for Coronavac,” Anvisa said in a statement on its website on Monday.
“The vaccine has had an emergency use authorization in China since June of this year. The Chinese criteria for granting emergency use authorization are not transparent, and there is no available information about the criteria currently in use by Chinese authorities to make these decisions.”
China’s foreign ministry spokesman Wang Wenbin said on Tuesday China had been attaching “great importance” to the safety and efficacy of its vaccines.
The Butantan Institute, which produces Coronavac, warned, moreover, that it will skip the stage of emergency use and go straight to the definitive registration, which requires more information and takes more time to be granted. On Monday it postponed the result of final report on the efficacy of the vaccine developed by the Chinese Sinovac.